Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The compan…
Drug Manufacturers - General
US, New York [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 72.67 | 72.92 | 73.65 | 73.84 | 71.81 | 75.24 | 76.39 | 74.54 | 70.80 | 70.98 | 69.10 | 72.31 | 78.57 | 78.04 | 76.24 | |
| Profit Margin | 56.42 | 15.92 | 17.46 | 11.12 | 15.64 | 12.62 | 9.81 | 22.94 | 4.85 | 21.95 | 13.15 | -21.16 | 15.08 | 13.71 | 17.83 | |
| Operating Margin | 30.51 | 28.77 | 31.29 | 22.31 | 17.89 | 10.79 | 10.45 | 23.36 | 16.61 | 22.69 | 20.90 | 12.06 | 21.90 | 22.37 | 38.31 | |
|
EPS Growth
|
103.02 | -66.36 | 20.44 | -46.33 | 33.33 | -22.44 | -19.84 | 175.26 | -77.15 | 396.72 | -33.33 | -297.03 | 179.15 | -5.71 | 30.64 | |
| EPS USD | 538.00 | 181.00 | 218.00 | 117.00 | 156.00 | 121.00 | 97.00 | 267.00 | 61.00 | 303.00 | 202.00 | -398.00 | 315.00 | 297.00 | 388.00 | |
| Return on Assets (ROA) | 34.22 | 9.98 | 11.25 | 5.46 | 6.64 | 5.94 | 5.12 | 13.22 | 3.00 | 46.46 | 2.65 | -7.59 | 6.40 | 6.53 | 8.43 | |
| Return on Equity (ROE) | 71.49 | 19.74 | 23.25 | 14.39 | 16.91 | 13.49 | 11.38 | 27.55 | 8.58 | 35.29 | 6.66 | -23.78 | 19.46 | 20.37 | 27.27 | |
| Return on Invested Capital (ROIC) | 21.35 | 19.69 | 23.35 | 20.00 | 11.13 | 6.44 | 6.44 | 15.11 | 3.33 | 19.83 | 3.83 | 7.50 | 10.79 | 11.84 | 23.17 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | 100 | - - | - - | - - | - - | - - | |
| Debt/Assets | 20.51 | 17.52 | 16.66 | 20.60 | 21.61 | 23.21 | 21.07 | 19.90 | 23.73 | 68.95 | 36.58 | 43.61 | 41.71 | 42.05 | 43.57 | |
| Debt/Equity | 42.86 | 34.65 | 34.41 | 54.28 | 55.04 | 52.73 | 46.89 | 41.47 | 67.81 | 52.38 | 92.13 | 136.62 | 126.85 | 131.09 | 140.89 | |
| Debt/EBITDA | -30.67 | 6.27 | -4.00 | 131.61 | 147.18 | 105.95 | 176.83 | 43.99 | 44.44 | 7.22 | 533.29 | 250.59 | 156.66 | 158.58 | 156.44 | |
|
Debt/Capitalization
|
30.00 | 25.73 | 25.60 | 35.18 | 35.50 | 34.53 | 31.92 | 29.31 | 40.41 | 34.37 | 47.95 | 57.74 | 55.92 | 56.73 | 58.49 | |
| Long-Term Debt/Capitalization | 29.23 | 25.32 | 25.20 | 32.53 | 34.50 | 32.78 | 31.47 | 26.11 | 37.27 | 28.69 | 46.06 | 56.52 | 52.97 | 53.90 | 56.47 | |
| Interest Debt per Share USD | 3.32 | 3.26 | 3.32 | 4.54 | 5.19 | 4.85 | 4.12 | 4.11 | 4.96 | 4.61 | 28.27 | 23.51 | 21.13 | 19.69 | 20.60 | |
| Debt Growth | -5.61 | -14.40 | 0.85 | 34.66 | 12.79 | -6.09 | -14.59 | 0.28 | 18.69 | -7.70 | 546.86 | 8.70 | -11.76 | -10.70 | 1.84 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 221.10 | 196.96 | 196.89 | 115.00 | 152.06 | 172.65 | 129.91 | 155.01 | 155.33 | 521.67 | 160.37 | 158.24 | 152.10 | 124.59 | 142.71 | |
| Quick Ratio | 184.98 | 159.98 | 160.36 | 71.41 | 63.38 | 127.94 | 106.89 | 134.52 | 137.11 | 871.93 | 126.08 | 127.53 | 135.98 | 105.94 | 123.73 | |
| Cash Ratio | 121.70 | 74.68 | 74.24 | 20.00 | 28.83 | 65.84 | 29.75 | 47.92 | 56.69 | 405.81 | 67.45 | 76.24 | 63.92 | 41.68 | 51.50 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | 300 | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | 363.77 | 438.29 | 404.48 | 278.21 | 308.34 | 252.05 | 320.15 | 398.55 | 520.24 | 547.87 | 188.17 | 567.65 | 474.46 | 433.39 | 401.69 | |
| Receivables Turnover | 594.44 | 559.89 | 567.57 | 571.55 | 487.65 | 468.41 | 385.21 | 350.48 | 329.78 | 378.22 | 340.21 | 500.15 | 370.61 | 331.20 | 294.85 | |
| Payables Turnover | 300.41 | 266.11 | 215.06 | 209.36 | 180.50 | 158.10 | 249.78 | 297.24 | 269.84 | 346.04 | 330.39 | 433.95 | 337.06 | 333.45 | 328.11 | |
|
Asset Turnover
|
60.66 | 62.70 | 64.43 | 49.09 | 42.46 | 47.05 | 52.16 | 57.63 | 61.92 | 211.66 | 20.12 | 35.89 | 42.43 | 47.68 | 47.30 | |
| Fixed Turnover | 372.07 | 417.75 | 469.90 | 330.41 | 357.83 | 359.50 | 375.34 | 390.10 | 415.44 | 448.80 | 418.19 | 630.36 | 665.69 | 617.51 | 560.05 | |
| Coverage | ||||||||||||||||
| Interest Coverage | 3,118.48 | 3,865.52 | 4,584.14 | 2,160.44 | 1,472.86 | 844.33 | 940.22 | 2,717.96 | 1,760.20 | 2,796.72 | 832.93 | 361.13 | 761.54 | 838.31 | 1,478.73 | |
| Asset Coverage | 300 | 300 | 400 | 200 | 200 | 300 | 300 | 300 | 200 | 100 | 100 | - - | 100 | 100 | 100 | |
| Cash Flow Coverage (CFGR) | 63.91 | 82.48 | 88.14 | 93.87 | 42.51 | 40.19 | 27.39 | 42.49 | 66.25 | 80.83 | 16.97 | 27.19 | 35.54 | 32.09 | 33.43 | |
| EBITDA Coverage | 2,300 | 4,500 | 4,900 | 2,300 | 1,600 | 1,000 | 1,300 | 3,300 | 2,900 | 3,300 | 1,000 | 1,000 | 1,500 | 1,600 | 1,600 | |
| Dividend Coverage | -400 | -100 | -100 | - - | -100 | - - | - - | -100 | - - | -100 | -100 | 200 | -100 | -100 | -100 | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | 4.98 | 4.85 | 3.76 | 4.20 | 2.64 | 2.45 | 2.16 | 2.61 | 2.56 | 3.08 | 2.45 | 2.91 | 3.17 | 3.02 | 4.47 | |
| Earnings Yield | 21.29 | 6.84 | 6.19 | 3.60 | 2.93 | 2.05 | 1.42 | 4.56 | 1.00 | 5.83 | 3.14 | -6.42 | 5.05 | 4.13 | 7.56 | |
|
Price/Earnings (P/E)
|
469.69 | 1,462.29 | 1,615.21 | 2,776.80 | 3,409.23 | 4,880.87 | 7,061.14 | 2,191.01 | 10,010.49 | 1,714.12 | 3,182.44 | -1,557.13 | 1,979.97 | 2,422.21 | 1,322.87 | |
| Price/Earnings Growth (PEG) | 4.56 | -22.04 | 79.01 | -59.93 | 102.28 | -217.55 | -356.00 | 12.50 | -129.75 | 4.32 | -95.47 | 5.24 | -11.05 | -423.89 | 43.18 | |
|
Price/Book (P/B)
|
335.80 | 288.68 | 375.46 | 399.51 | 576.60 | 658.58 | 803.82 | 603.65 | 858.58 | 604.97 | 212.11 | 370.32 | 385.24 | 493.40 | 360.72 | |
| Price/Tangible Book (P/TB) | 335.80 | 288.68 | 375.46 | 399.51 | 576.60 | 658.58 | 803.82 | 603.65 | 858.58 | 604.97 | 212.11 | 370.32 | 385.24 | 493.40 | 360.72 | |
| Price/Sales (P/S) | 265.01 | 232.81 | 282.00 | 308.87 | 533.28 | 615.99 | 692.47 | 502.67 | 485.20 | 376.24 | 418.60 | 329.42 | 298.54 | 332.01 | 235.88 | |
|
Price/Cash Flow (P/CF)
|
1,226.16 | 1,010.03 | 1,237.77 | 784.11 | 2,464.84 | 3,107.14 | 6,259.44 | 3,426.43 | 1,911.01 | 1,429.01 | 1,356.69 | 996.75 | 854.44 | 1,172.92 | 765.95 | |
| Price/Free CF (P/FCF) | 1,494.56 | 1,115.32 | 1,339.32 | 851.33 | 2,904.87 | 3,730.46 | 11,331.32 | 5,972.68 | 2,388.76 | 1,701.41 | 1,513.54 | 1,053.19 | 909.02 | 1,282.67 | 839.15 | |
| Price/Operating CF (P/OCF) | 1,226.16 | 1,010.03 | 1,237.77 | 784.11 | 2,464.84 | 3,107.14 | 6,259.44 | 3,426.43 | 1,911.01 | 1,429.01 | 1,356.69 | 996.75 | 854.44 | 1,172.92 | 765.95 |